Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars
- PMID: 32623769
- DOI: 10.1002/humu.24074
Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars
Erratum in
-
Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars.Hum Mutat. 2022 Dec;43(12):2328. doi: 10.1002/humu.24500. Epub 2022 Nov 30. Hum Mutat. 2022. PMID: 36448424 No abstract available.
Abstract
It is possible to estimate the prior probability of pathogenicity for germline disease gene variants based on bioinformatic prediction of variant effect/s. However, routinely used approaches have likely led to the underestimation and underreporting of variants located outside donor and acceptor splice site motifs that affect messenger RNA (mRNA) processing. This review presents information about hereditary cancer gene germline variants, outside native splice sites, with experimentally validated splicing effects. We list 95 exonic variants that impact splicing regulatory elements (SREs) in BRCA1, BRCA2, MLH1, MSH2, MSH6, and PMS2. We utilized a pre-existing large-scale BRCA1 functional data set to map functional SREs, and assess the relative performance of different tools to predict effects of 283 variants on such elements. We also describe rare examples of intronic variants that impact branchpoint (BP) sites and create pseudoexons. We discuss the challenges in predicting variant effect on BP site usage and pseudoexonization, and suggest strategies to improve the bioinformatic prioritization of such variants for experimental validation. Importantly, our review and analysis highlights the value of considering impact of variants outside donor and acceptor motifs on mRNA splicing and disease causation.
Keywords: ESE; ESS; branchpoint; hereditary cancer genes; pseudoexon; splicing regulatory elements.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Acedo, A., Hernández-Moro, C., Curiel-García, Á., Díez-Gómez, B., & Velasco, E. A. (2015). Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons. Human Mutation, 36(2), 210-221. https://doi.org/10.1002/humu.22725
-
- Acedo, A., Sanz, D. J., Durán, M., Infante, M., Pérez-Cabornero, L., Miner, C., & Velasco, E. A. (2012). Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes. Breast Cancer Research, 14(3), R87. https://doi.org/10.1186/bcr3202
-
- Anczukow, O., Buisson, M., Leone, M., Coutanson, C., Lasset, C., Calender, A., … Mazoyer, S. (2012). BRCA2 deep intronic mutation causing activation of a cryptic exon: Opening toward a new preventive therapeutic strategy. Clinical Cancer Research, 18(18), 4903-4909. https://doi.org/10.1158/1078-0432.ccr-12-1100
-
- Baralle, M., Skoko, N., Knezevich, A., De Conti, L., Motti, D., Bhuvanagiri, M., … Baralle, F. E. (2006). NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Letters, 580(18), 4449-4456. https://doi.org/10.1016/j.febslet.2006.07.018
-
- Buratti, E., Muro, A. F., Giombi, M., Gherbassi, D., Iaconcig, A., & Baralle, F. E. (2004). RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Molecular and Cellular Biology, 24(3), 1387-1400. https://doi.org/10.1128/MCB.24.3.1387-1400.2004
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous